Position in LQDA
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$9,337,064
New position
Shares Held
247,405
first reported quarter
Ownership
0.278%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Capricorn Fund Managers Ltd holds $26,038,930 across 3 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (35.9% of the industry book) .
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,337,064 | 247,405 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||